Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Accuray To Report Fiscal 2017 Second Quarter Financial Results On January 31, 2017

ARAY

PR Newswire

SUNNYVALE, Calif., Jan. 17, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal second quarter ended December 31, 2016 on Tuesday, January 31, 2017 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.

The conference call dial-in numbers are 855-867-4103 (USA) or 262-912-4764 (International).  In addition, a dial up replay of the conference call will be available approximately one hour after the call's conclusion for one week.  The replay number is 855-859-2056 (USA), or 404-537-3406 (International), Conference ID: 52778138.

A live webcast of the call will also be available from the Investor Relations section of the Company's website at www.accuray.com/investors.  A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the third quarter of fiscal 2017, ending March 31, 2017.

About Accuray

Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives.  The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.  For more information, please visit www.accuray.com

Contacts:




Investors:  

Brian Moore, EVC Group, 310-770-0389, bmoore@evcgroup.com


Doug Sherk, EVC Group, 415-652-9100, dsherk@evcgroup.com



Media: 

Beth Kaplan


Public Relations Director, Accuray


408-789-4426


bkaplan@accuray.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/accuray-to-report-fiscal-2017-second-quarter-financial-results-on-january-31-2017-300391608.html

SOURCE Accuray Incorporated



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today